Treatment and overall survival (OS) in metastatic renal cell carcinoma (mRCC): A Swedish population-based study (2000-2008).
Ulrika Harmenberg
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Sven Lundstam
Honoraria - GlaxoSmithKline; Pfizer; Roche
Research Funding - Pfizer; Wyeth
Thomas Wahlgren
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Jan Kowalski
Consultant or Advisory Role - Pfizer
Maria Jakobsson
Employment or Leadership Position - Pfizer
Rickard Sandin
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Börje Ljungberg
Consultant or Advisory Role - Bayer; GlaxoSmithKline; Novartis; Pfizer
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer
Per Sandström
Consultant or Advisory Role - GlaxoSmithKline; Novartis; Pfizer
Honoraria - Bayer Schering Pharma; GlaxoSmithKline; Pfizer
Research Funding - Bayer Schering Pharma; Pfizer